Skip to main content

Effect of Chronic Levodopa, Bromocriptine and SKF-38393 on Dyskinesia and Dopamine Receptors in MPTP-parkinsonian Monkeys

  • Chapter
Pharmacology and Functional Regulation of Dopaminergic Neurons

Abstract

The existence of two brain dopamine (DA) receptor subtypes (D-1 and D-2) has now gained widespread acceptance. More recently, it has been reported that D-1 and D-2 receptors in normosensitive striatum are functionally linked (Barone et al., 1986). The use of the D-2 selective agonist, bromocriptine, in previously untreated parkinsonian patients has been reported to induce little or no dyskinesia (Lees and Stern, 1981). The interaction between D-1 and D-2 receptors in treatment of Parkinson’s disease may therefore be important particularly for the induction of dyskinesia observed after therapy with L-DOPA, a mixed DA agonist.

This research was supported by the Parkinson Foundation of Canada and Sandoz Canada. Participation to this symposium was financed by the Government of Quebec and Sandoz Canada.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Barone, P., Davis, T.A., Braun, A.R. and Chase, T.N. (1986). Dopaminergic mechanisms and motor function: characterization of D-1 and D-2 dopamine receptor interactions. Eur. J. Pharmacol., 123, 109–114.

    Article  CAS  PubMed  Google Scholar 

  • BĂ©dard, P.J., Di Paolo, T., Falardeau, P. and Boucher, R. (1986). Chronic treatment with Levodopa, but not bromocriptine induces dyskinesia in MPTP-parkinsonian monkeys. Correlation with [3H]spiperone binding. Brain Res., 379, 294–299.

    Article  PubMed  Google Scholar 

  • Lees, A.J. and Stern, G.M. (1981). Sustained bromocriptine therapy in previously untreated patients with Parkinson’s disease. J. Neurol. Neurosurg. Psychiat., 44, 1020–1023.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Copyright information

© 1988 T. Di Paolo, P. Falardeau and P. Bédard

About this chapter

Cite this chapter

Di Paolo, T., Falardeau, P., BĂ©dard, P. (1988). Effect of Chronic Levodopa, Bromocriptine and SKF-38393 on Dyskinesia and Dopamine Receptors in MPTP-parkinsonian Monkeys. In: Beart, P.M., Woodruff, G.N., Jackson, D.M. (eds) Pharmacology and Functional Regulation of Dopaminergic Neurons. Satellite Symposia of the IUPHAR 10th International Congress of Pharmacology. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-10047-7_60

Download citation

Publish with us

Policies and ethics